Cognetti DM, Curry JM, Johnson J, Kwon M, et al. Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck 2025 Aug 25. doi: 10.1002/hed.70014.
PMID: 40852760